BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#109 of 347

Roy Buchanan

JMP Securities · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Roy Buchanan is an equity research analyst at JMP Securities. Bullish Whales has scored 28 of their stock calls across 8 companies. Their picks beat their sector 45% of the time over the next 12 months, and their price targets were reached 28% of the time within a year.

Win % vs sector
45%
PT Hit % (12mo)
28%
Avg sector-excess
−1.7%
Scored calls
28
Tickers
8
Tier
Provisional

Track record

Bullish Whales has scored 28 of Roy Buchanan's stock calls across 8 companies, dating back to 2021. Their rated stocks beat their own sector 45% of the time over the next 12 months. On a typical call, a Buchanan pick returned −1.7% more than its sector over the following year.

Of the scored calls, 28 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ENTAEnanta Pharmaceuticals Inc
Buy$24.00Jun 2025+45.4%Miss
ANTXAN2 Therapeutics Inc
Buy$2.00May 2025+297.7%Hit
ANTXAN2 Therapeutics Inc
Buy$5.00Mar 2025+148.4%Hit
INOInovio Pharmaceuticals Inc
Buy$18.00Mar 2025−27.4%Miss
ANTXAN2 Therapeutics Inc
Buy$5.00Feb 2025−14.8%Miss
ESPREsperion Therapeutics Inc
Buy$4.00Feb 2025+75.0%Hit
ENTAEnanta Pharmaceuticals Inc
Buy$21.00Feb 2025+134.1%Miss
ANTXAN2 Therapeutics Inc
Buy$5.00Feb 2025−9.3%Miss
IRWDIronwood Pharmaceuticals Inc
Buy$14.00Jan 2025+101.8%Miss
ESPREsperion Therapeutics Inc
Buy$7.00Jan 2025+38.5%Miss
INOInovio Pharmaceuticals Inc
Buy$18.00Jan 2025−32.2%Miss
ENTAEnanta Pharmaceuticals Inc
Buy$21.00Nov 2024+48.1%Miss
HOOKHookipa Pharma Inc
Buy$7.00Nov 2024−68.3%Miss
ANTXAN2 Therapeutics Inc
Buy$5.00Nov 2024−25.4%Miss
ENTAEnanta Pharmaceuticals Inc
Buy$22.00Oct 2024+11.7%Miss
ENTAEnanta Pharmaceuticals Inc
Buy$22.00Sep 2024+56.5%Miss
HOOKHookipa Pharma Inc
Buy$24.00Aug 2024−70.2%Miss
ANTXAN2 Therapeutics Inc
Buy$3.00Aug 2024+13.3%Miss
ABUSArbutus Biopharma Corp
Buy$5.00Aug 2024+0.1%Miss
ENTAEnanta Pharmaceuticals Inc
Buy$22.00May 2024−57.2%Miss
ABUSArbutus Biopharma Corp
Buy$4.00Apr 2024+7.5%Hit
ANTXAN2 Therapeutics Inc
Buy$6.00Apr 2024−60.3%Miss
INOInovio Pharmaceuticals Inc
Buy$1.00Jan 2024−78.8%Hit
ANTXAN2 Therapeutics Inc
Buy$30.00Jan 2024−94.0%Miss
ENTAEnanta Pharmaceuticals Inc
Buy$23.00Nov 2023−10.3%Miss
ABUSArbutus Biopharma Corp
Buy$6.00Jul 2023+24.3%Miss
ABUSArbutus Biopharma Corp
Buy$6.00Mar 2023−31.8%Miss
IBIOiBio, Inc. Common Stock
Buy$1.50Nov 2021−98.1%Miss
Go to

Roy Buchanan: analyst track record FAQ

Is Roy Buchanan a good stock analyst?

Yes, by track record. Roy Buchanan ranks number 109 of 347 of the analysts Bullish Whales scores, with a BW Score of 45 out of 100. Past results do not guarantee future ones.

What is Roy Buchanan's win rate?

Roy Buchanan's win rate is 45%. Across 28 scored calls, their rated stocks beat their sector 45% of the time over the next 12 months. On a typical call they returned −1.7% more than the sector.

What stocks and sectors does Roy Buchanan cover?

Roy Buchanan covers 8 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Roy Buchanan's price targets accurate?

Roy Buchanan's price targets are reached within 12 months 28% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Roy Buchanan's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Roy Buchanan rank among Wall Street analysts?

Roy Buchanan ranks number 109 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30